PITTSBURGH -- Retailers tracking how the FDA “deeming” rules, as currently written, will affect different aspects of the tobacco category, may take heart in that their largest-volume segment in cigarettes will likely feel the least impact, according to a recently released report.
In a study tracking unit-shipping movement, the U.S. Food and Drug Administration’s newly deemed regulations will possibly affect only 4% of the volume c-store retailers sell, compared to other more hard-hit categories such as cigars (49%) and vapor (100%).
Still, the study from Pittsburgh-based Management Science Associates (MSA) released last fall, says discount cigarettes will be more affected than premium brands. Here’s a few cigarette insights from the study …